FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

DSCSA Enhanced System Draft Guidance Explained

Winston & Strawn attorneys outline an FDA draft guidance on the enhanced Drug Supply Chain Security Act system for tracking and tracing drugs at the p...

Biologics

Emergent Details New Quality Enhancement Plan

Emergent Biosolutions responds to an FDA-483 about issues at its Bayview facility that manufactured Covid-19 vaccines and was the subject of a cross-c...

Medical Devices

iStar Medical Glaucoma Implant Trial OKd

FDA grants iStar Medical an IDE to begin a pivotal trial with its Miniject implant in over 350 patients with primary open angle glaucoma.

Medical Devices

FDA Clears Palliare Insufflation Expanded Use

FDA clears a Palliare 510(k) for the END-200 tubeset that expands the use of its EVA15 continuous pressure insufflation technology from laparoscopic s...

Human Drugs

BIO Suggests Improvements to 3 Covid-19 Guidances

BIO discusses how three FDA emergency Covid-19 guidances may inform future inspection practices after the public health emergency ends.

Animal Drugs

FDA OKs Tanovea for Lymphoma in Dogs

FDA approves VetDCs Tanovea (rabacfosadine injection) to treat lymphoma in dogs.

Medical Devices

FDA Safety Concerns with NuVasive MAGEC Implants

FDA says it is working with NuVasive to resolve safety issues with its MAGEC growing spinal rod system.

FDA General

White House, Senators Fighting Over FDA Head: CNN

CNN reports that Janet Woodcock is no longer the front-runner to be named FDA commissioner due to concerns voiced by some Senate Democrats.

Biologics

Scarsdale Integrative Marketing Unapproved Cell Products: FDA

The CBER Office of Compliance and Biologics Quality cautions Scarsdale Integrative Family Medicine that it is marketing unapproved cellular products a...

Federal Register

Stromectol Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Mercks Stromectol (ivermectin) tablets, 6 mg, were not withdrawn from sale for reasons of safety or effec...